2,415
Views
4
CrossRef citations to date
0
Altmetric
Coronavirus – Review

Public acceptability of COVID-19 vaccines and its predictors in Middle ‎Eastern/North African (MENA) countries: a systematic review‎

, , , , , , , , , , , , , & show all
Article: 2043719 | Received 23 Dec 2021, Accepted 15 Feb 2022, Published online: 23 Mar 2022

ABSTRACT

Introduction

COVID-19 vaccines emerged as a worldwide hope to contain the pandemic. However, many people ‎are still hesitant to receive these vaccines. We aimed to systematically review the public knowledge, perception, and acceptability of COVID-19 vaccines in the Middle East and North Africa (MENA) countries and the predictors of vaccine acceptability in this region.

Methods

We systematically searched databases of PubMed, Scopus, Web of Science, and Cochrane and retrieved ‎all relevant studies by 5 August 2021.

Results

There was a considerable variation in the COVID-19 vaccine acceptance ‎rates, from 12% in a study from Israel to 83.3% in Kuwait, although two other studies from Israel mentioned 75% ‎and 82.2% acceptability rates. Concerns about the side effects and safety of the vaccine were the main reasons for ‎the lack of acceptability of taking the vaccine, which was reported in 19 studies. ‎

Conclusion

Several factors, such as age, gender, education level, and comorbidities, ‎are worthy of attention as they could expand vaccine coverage in the target population.‎

Introduction

Coronavirus 2019 (COVID-19) emerged as a pandemic and a serious threat to the public health in 2020.Citation1–4 Many countries have accelerated vaccine research and developed vaccination programs against COVID-19.Citation5–7 With emerging variants that exhibit more transmissibility or disease severity, such as delta and omicron variants, the worldwide hope relies on higher vaccination rates to decrease the disabilities and deaths related to the COVID-19.Citation3,Citation8,Citation9 Although vaccine research has progressed rapidly, public acceptance and negative attitudes toward COVID-19 vaccines are significant challenges. The willingness to receivethe COVID-19 vaccine is recognized as a key issue in predictingthe success of a vaccination program.Citation10

The acceptability of the vaccines and people’s attitude toward them determine the rates of vaccinations and serves an important role in containing the pandemic. Several factors were suggested to affect the vaccine acceptability among the general population, such asthe previous experience of vaccine, level of education and knowledge, risk perception and trust, perception of vaccine effectiveness, having underlying diseases, mental and cultural norms, religious and moral beliefs, etc.Citation11–13 Understanding the severity and risks of the COVID-19 is also associated with public awareness of the dangers and encourages people to be more involved in disease prevention.Citation12,Citation14,Citation15 Nevertheless, such factors are not extensively reviewed by the previous studies. The current global acceptance of the COVID-19 vaccines varies from 35% to 98% across countries, indicating that policymakers need to understand the public attitude to assist the large-scale vaccination programs.Citation16–18

The Middle East and North Africa (MENA) region was affected early in the COVID-19 epidemic, and there were a large number of cases in some countries (e.g., Iran).Citation19 The first COVID-19 confirmed cases in MENA date back to February 2020 and have been reported in the UAE, Iran, and Egypt.Citation20 Although some original studies on vaccine acceptability exist that measure the public perception toward vaccination in the countries of the region, no systematic reviews are available to summarize the findings for this region. Furthremore, the causes of vaccine hesitation and lack of acceptability are not studied in details for the region. Bearing these facts in mind, this study aimed to systematically review thepublic knowledge, perception, and acceptability of COVID-19 vaccines in the MENA countries and the predictors of vaccine acceptability in this region, as making policies revolving around such factors may increase the willingness of the people to receive the COVID-19 vaccines.

Methods

Overview

We systematically searched the online databases of PubMed, Scopus, Web of Science, and Cochraneand retrieved the relevant studies by 5th August 2021. The retrieved records were downloaded into the EndNote 20 program for study selection. The study selection process consisted of two steps; first, the records underwent a title/abstract screening process. Then, studies selectedin the title/abstract screening were included in the full-text screening, and the eligible articles were included in the final review.

Search strategy

We searched for the keywords related to “COVID-19”, “vaccination”, and “MENA and its countries”. The detailed keywords and search strategy be found in Supplementary material 1.

Study selection

We included the original studies that evaluated public attitude, perception, and acceptability of COVID-19 vaccines in the MENA region. The exclusion criteria were as follows:

  1. Reviews, systematic review, meta-analyses, and any other studies without original data

  2. Case reports

  3. Abstracts or other studies lacking available full texts

  4. Studies from the world regions other than MENA

  5. Non-English studies

Data extraction

We summarized the included publications into a word table () that represents theyear andcountry of study, study design (e.g., cross-sectional study), samplesize, patient’s mean age, gender,comorbidity, history of influenza vaccination (%), participants’ education and occupation, acceptability rate of COVID-19 vaccine (%), reasons for lack of acceptability,respondents’ attitudes toward vaccination,reasons and predictors ofacceptability, and a summary of findings. Three independent researchers undertook this process, and a final investigator reviewed the extracted data and addressedany possible discrepancies between the researchers.

Table 1. Included studies and summary of their findings

Results

A total of 45cross-sectional studies were included in this review (). All studies wereconducted usinga phone interview or a self-reported online questionnaire. Most of the studies were fromSaudi Arabia, Jordan, and Israel, with 11, 7, and 5 studies, respectively.The majority of studies had a high number of participants;15 of them polled 1000–3000 participants, 12 polled over 3000 participants, and 18had less than 1000 participants.

Figure 1. The PRISMA flowchart for included articles

Figure 1. The PRISMA flowchart for included articles

There hasbeen a considerable variation in COVID-19 vaccine acceptance between the studies. The highest acceptance rate was reported in a survey conducted in Kuwait (83.3%); while, the lowest rate of acceptance was reported in a survey conducted in Israel with an acceptance rate of 12%. Some countries had higher acceptance: one study in Kuwait (83%), two studies in Israel (82.2% and 75%),andone study in Saudi Arabia (70.7%).The acceptance rate was not reported in six studies. Concernsrelated to theside effects and safety of the vaccine were the main reasons for the lack of acceptability of the vaccines reported in 19studies.

A considerably wide variety of acceptability rates have been reported across thestudies included in this review.Depending on the demographic characteristics of the participants, such as age, gender, education, and region.Elgendy and Abdelrahim, Fares et al., and Temsah et al. reported that the safety and efficacy of the currently available COVID-19 vaccines against severe complications is another predictor of high vaccine acceptability.Citation21,Citation22,Citation25 The type of vaccine, side effects, and its manufacturing company has also played a pivotal role in people’s willingness to receive vaccines.Citation22,Citation26 Interestingly, other studies conducted on younger than 25-year-old participants have also shown a high rate of vaccine acceptability.Citation29 In contrast, studies with a wider range of participants that included middle-aged adults demonstrated lower vaccine acceptability rates than the groups mentioned above.Citation25,Citation30,Citation31

Individuals who have received their influenza vaccine appeared to be more willing to get vaccinated against the COVID-19,Citation27,Citation28,Citation32–35 Nevertheless, Baghdad et al. did not find correlations between intentions for accepting influenza vaccinations and the COVID-19 vaccines’ acceptability,Citation37 while Dror et al. reported influenza vaccine acceptance as the most significant predictor of willingness to the COVID-19 vaccines.Citation34

Males tended to have higher acceptability rates compared to the women,Citation36–38,Citation40–43 Patients with underlying conditions that found themselves at higher risk of severe COVID-19 had better acceptability for the COVID-19 vaccines.Citation44, Participants involved in healthcare services tend to have a higher vaccine acceptability rate compared to other groups. In a group of 628 medical students and nursing students in Israel, the acceptability rate was 82.2%.Citation45 However, the acceptability rate among 2133 Egyptian medicine, nursing, dentistry, and pharmacy students reported to be 34.9%.Citation39 Temsah et al. also reported a relatively low acceptability rate (20.9–24.4%) in a sample of 15,124 physicians, nurses, and health care providers in Saudi Arabia.Citation22 Those with non-medical but higher degrees are more likely to find their desired information about the vaccines and understand the arguments supporting vaccination.

Discussion

In this study, here we reviewed the acceptability rate and influencing factors of COVID-19 vaccinationsuch as age, sex, education level, and comorbidities of the participants. The reasons and rationale leading to higher or lower acceptability rates are discussed here to enhancethe awareness ofvaccine acceptability and influencing factors.

Whether subjective or objective, various factors were shown to contribute to a high vaccine acceptability rate among subjects. Being concerned about the risk of contracting COVID-19 infection, especially among those with chronic diseases such as diabetes mellitus, contributed significantly to the willingness to get vaccinated.Citation30,Citation35,Citation38,Citation40,Citation46 Another contributing factor has been the strong urge to help eradicate the COVID-19 pandemic and recommence everydaylifeCitation21,Citation41,Citation42,Citation48 by achieving herd immunity through vaccination. Moreover, Burhamah et al. and Fares et al. reported a tendency to travel as a criticalfactor in increasing vaccine acceptability.Citation25,Citation41

Several studies demonstrated that subjects who had previously received influenza vaccine were more likely to accept COVID-19 vaccine injection,Citation27,Citation32,Citation35,Citation46,Citation49 which may be the result from observing vaccines’ effectiveness in preventing flu. Two cross-sectional studies in Qatar and another in Syria stated that comprehensive knowledge of vaccines and their function accounts for another factor leading to high vaccine acceptability.Citation30,Citation36

As different studies have reported various vaccine acceptability rates concerning the mean age of participants, it is difficult to make a conclusive deduction. However, generally speaking, as reported by Mejri et al., those with an older age have shown more willingness for receiving the COVID-19 vaccine.Citation47 This may stem from the fact that they are at greater risk of being infected and having severe complications due to older age and comorbidities

The results of included studies imply that generally, women hesitate more for getting vaccinated. Studies with a male percent of more than 40% reported a significantly higher rate of vaccine acceptability than most of the studies involving more women,Citation36–38,Citation40–42,Citation43 However, the intriguing point is that some exception studies that, despite involving more women, demonstrated a high rate of acceptability,Citation50,Citation51 surprisingly sometimes even higher than other studies.Citation52

Patients at higher risk of COVID-19 infection, particularly diabetic and immunocompromised patients,have more tendency to get their COVID-19 vaccine shot. In a report from Kuwait in which 24% of the participants had at least one medical condition such as diabetes, hypertension, stroke, and asthma, 83% of participants were convinced to take their vaccine.

The impact of one’s education level on vaccine acceptability could not be emphasized enough, as higher education and especially medical education are due to help people understand the cons and pros of vaccines, as well as their mechanism of action and thus make them less afraid of the upcoming complications. The acceptability of vaccines could be diminished by conspiracy beliefs, especially among those with lower education levels.Citation31

Just acceptability and hesitancy themselves, the reasons for them also vary with education level, age, and medical conditions.The uncertainty about the safety and effectiveness of vaccines,Citation24,Citation36,Citation44,Citation53 misbeliefs, and conspiracies spread through social mediaCitation27,Citation28,Citation52 are often reported as the reasons for mistrust of COVID-19 vaccines. Some claimed the lack of sufficient clinical trials as the logic of their hesitancy.Citation25 Many hesitate the vaccines because they do not have trust in their efficacy. Either not believing the authorities or the clinical trials, these participants tend to protect themselves against COVID-19 through natural exposure to the virus, which is not supported by the same evidence compared to vaccines.Citation36

Conclusion

The acceptability of COVID-19 vaccines depends on many variables and could not be predicted using only one or a few of them. Age, education level, and comorbidities are the main prognostic factors based on which a higher or lower acceptability rate could be explained. Furthermore, evaluation of the popular reasons leading to lack of acceptability would result in a better understanding of the concerns of the population, which could empower the authorities to plan for better vaccination coverage. Also, approaching each group of people with a coherent strategy and providing them with relevant information will with great chance facilitate the process of vaccination. At last, better control ofvaccine information spread through social networks can be helpful in diminishing the conspiracy beliefs leading to mistrusting the vaccination process.

Authors' contributions

All authors participated in all stages of the manuscript drafting.

Data availability materials

The authors stated that all information provided in this article could be shared

Ethics approval and consent to participate

The present study was extracted from the research project with code IR.KHALUMS.REC.1399.001 entitled “Investigation of effective drugs for people affected by Coronavirus disease 2019 (COVID-19) in Imam Khomeyni hospital” conducted at Khalkhal University of Medical Sciences in 2020.

Acknowledgments

The present study was conducted in collaboration with Khalkhal University of Medical Sciences, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, and Walailak University.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

References

  • Cucinotta D, Mjabmap V. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157.
  • Venugopal VC, Mohan A, Lkjapp C. Status of mental health and its associated factors among the general populace of India during COVID‐19 pandemic. Asia Pac Psychiatry. 2020;e12412.
  • SeyedAlinaghi S, Mirzapour P, Dadras O, Pashaei Z, Karimi A, MohsseniPour M, Soleymanzadeh M, Barzegary A, Afsahi AM, Vahedi F, et al. Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review. Eur J Med Res. 2021;26(1):51. doi:10.1186/s40001-021-00524-8.
  • SeyedAlinaghi S, Mehrtak M, MohsseniPour M, Mirzapour P, Barzegary A, Habibi P, Moradmand-Badie B, Afsahi AM, Karimi A, Heydari M, et al. Genetic susceptibility of COVID-19: a systematic review of current evidence. Eur J Med Res. 2021;26(1):46. doi:10.1186/s40001-021-00516-8.
  • WHO, World Health Organization World Health Organization. Genova S. Draft landscape and tracker of COVID-19 candidate vaccines. 2021. Geneva.
  • Mehraeen E, Dadras O, Afsahi AM, Karimi A, MohsseniPour M, Mirzapour P, Barzegary A, Behnezhad F, Habibi P, Salehi MA, et al. Vaccines for COVID-19: a review of feasibility and effectiveness. Infect Disord Drug Targets. 2021;21. doi:10.2174/1871526521666210923144837.
  • Mehraeen E, SeyedAlinaghi S, Karimi A. Can children of the Sputnik V vaccine recipients become symptomatic? Hum Vaccines Immunother. 2021;17(10):3500–16. doi:10.1080/21645515.2021.1933689.
  • Mehraeen E, Salehi MA, Behnezhad F, Moghaddam HR, SeyedAlinaghi S. Transmission modes of COVID-19: a systematic review. Infect Disord Drug Targets. 2021;21(6):e170721187995. doi:10.2174/1871526520666201116095934.
  • SeyedAlinaghi S, Karimi A, MohsseniPour M, Barzegary A, Mirghaderi SP, Fakhfouri A, Saeidi S, Razi A, Mojdeganlou H, Tantuoyir MM, et al. The clinical outcomes of COVID-19 in HIV-positive patients: A systematic review of current evidence. Immun Inflamm Dis. 2021;9(4):1160–85. doi:10.1002/iid3.497.
  • Lin Y, Hu Z, Zhao Q, Alias H, Danaee M, Lpjpntd W. Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China. PLoS Negl Trop Dis. 2020;14(12):e0008961.
  • Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger JA. Vaccine hesitancy: an overview. Hum Vaccines Immunother. 2013;9(8):1763–73. doi:10.4161/hv.24657.
  • Dadras O, Alinaghi SAS, Karimi A, MohsseniPour M, Barzegary A, Vahedi F, Pashaei Z, Mirzapour P, Fakhfouri A, Zargari G, et al. Effects of COVID-19 prevention procedures on other common infections: a systematic review. Eur J Med Res. 2021;26(1):67. doi:10.1186/s40001-021-00539-1.
  • SeyedAlinaghi S, Afsahi AM, MohsseniPour M, Behnezhad F, Salehi MA, Barzegary A, Mirzapour P, Mehraeen E, Dadras O. Late complications of COVID-19; a systematic review of current evidence. Arch Emerg Med. 2021;9(1):e14.
  • Shahin MAH, Rmjmecp H. Risk perception regarding the COVID-19 outbreak among the general population: a comparative Middle East survey. Middle East Current Psychiatry. 2020;27(1):1–19.
  • Echoru I, Ajambo PD, Bukenya EM. Acceptance and risk perception of COVID-19 vaccine in Uganda: a cross sectional study in Western Uganda. BMC Public Health. 2020;10(21): 1106.
  • Malik AA, McFadden SM, Elharake J, Sbje O. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine . 2020;26:100495.
  • Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–28. doi:10.1038/s41591-020-1124-9.
  • Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, Jit M. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021;397(10278):1023–34. doi:10.1016/S0140-6736(21)00306-8.
  • Karamouzian M, Njtlgh M. COVID-19 response in the Middle East and north Africa: challenges and paths forward. Lancet Global Health. 2020;8(7):e886–e7. doi:10.1016/S2214-109X(20)30233-3.
  • Mehtar S, Preiser W, Lakhe NA, Bousso A, TamFum J-J, Kallay O, Seydi M, Zumla A, Nachega JB. Limiting the spread of COVID-19 in Africa: one size mitigation strategies do not fit all countries. Lancet Global Health. 2020;8(7):e881–e3. doi:10.1016/S2214-109X(20)30212-6.
  • Elgendy MO, Abdelrahim MEA. Public awareness about coronavirus vaccine, vaccine acceptance, and hesitancy. J Med Virol. 2021;93(12):6535–43. doi:10.1002/jmv.27199.
  • Tahir AI, Ramadhan DS, Taha AA, Abdullah RY, Karim SK, Ahmed AK, Ahmed SF. Public fear of COVID-19 vaccines in Iraqi Kurdistan region: a cross-sectional study. Middle East Curr Psychiatry. 2021;28(1):46. doi:10.1186/s43045-021-00126-4.
  • Talmy T, Cohen B, Nitzan I, Ben Michael Y. Primary care interventions to address COVID-19 vaccine hesitancy among Israel Defense Forces soldiers. J Community Health. 2021;46.1–6.
  • Almaaytah, A. and A. Salama, Acceptance of COVID-19 vaccination among jordanian adults: a cross sectional study. Systematic Reviews in Pharmacy, 2020. 11(11): p. 1291–1297
  • Mohamad O, Zamlout A, AlKhoury N, Mazloum AA, Alsalkini M, Shaaban R. Factors associated with the intention of Syrian adult population to accept COVID19 vaccination: a cross-sectional study. BMC Public Health. 2021;21(1):1310. doi:10.1186/s12889-021-11361-z.
  • Sallam M, Dababseh D, Eid H, Al-Mahzoum K, Al-Haidar A, Taim D, Yaseen A, Ababneh NA, Bakri FG, Mahafzah A. High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: a study in Jordan and Kuwait among other Arab countries. Vaccines. 2021;9(1):42.
  • Alobaidi S. Predictors of intent to receive the COVID-19 vaccination among the population in the kingdom of Saudi Arabia: a survey study. J Multidiscip Healthc. 2021;14:1119–28. doi:10.2147/JMDH.S306654.
  • Alabdulla M, Reagu SM, Al-Khal A, Elzain M, Jones RM. COVID-19 vaccine hesitancy and attitudes in Qatar: a national cross-sectional survey of a migrant-majority population. Influenza Other Respi Viruses. 2021;15:361–70.
  • Alzahrani SH, Baig M, Alrabia MW, Algethami MR, Alhamdan MM, Alhakamy NA, Asfour HZ, Ahmad T. Attitudes toward the SARS-CoV-2 vaccine: results from the Saudi residents’ intention to get vaccinated against COVID-19 (SRIGVAC) study. Vaccines. 2021;9(7):798. doi:10.3390/vaccines9070798.
  • AlAwadhi EA, Zein D, Mallallah F, Haider NB, Hossain A. Monitoring COVID-19 vaccine acceptance in Kuwait during the pandemic: results from a national serial study. Risk Manage Healthc Policy. 2021;14:1413–29.
  • Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, Srouji S, Sela E. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020;35(8):775–79.
  • Abu-Farha R, Mukattash T, Itani R, Karout S, Khojah HMJ, Abed Al-Mahmood A, Alzoubi KH. Willingness of Middle Eastern public to receive COVID-19 vaccines. Saudi Pharm J: SPJ. 2021;29(7):734–39. doi:10.1016/j.jsps.2021.05.005.
  • Alawadhi E, Zein D, Mallallah F, Haider NB, Hossain A. Monitoring COVID-19 vaccine acceptance in kuwait during the pandemic: results from a national serial study. Risk Manage Healthc Policy. 2021;14:1413–29.
  • Magadmi RM, Kamel FO. Beliefs and barriers associated with COVID-19 vaccination among the general population in Saudi Arabia. BMC Public Health. 2021;21(1):1438. doi:10.1186/s12889-021-11501-5.
  • Baghdadi LR, Alghaihb SG, Abuhaimed AA, Alkelabi DM, Alqahtani RS. Healthcare workers’ perspectives on the upcoming COVID-19 vaccine in terms of their exposure to the Influenza vaccine in Riyadh, Saudi Arabia: a cross-sectional study. Vaccines. 2021;9(5):465. doi:10.3390/vaccines9050465.
  • Burhamah W, AlKhayyat A, Oroszlányová M, AlKenane A, Jafar H, Behbehani M, Almansouri A. The SARS-CoV-2 vaccine hesitancy among the general population: a large cross-sectional study from Kuwait. Cureus. 2021;13(7):e16261.
  • Al-Marshoudi S, Al-Balushi H, Al-Wahaibi A, Al-Khalili S, Al-Maani A, Al-Farsi N, Al-Jahwari A, Al-Habsi Z, Al-Shaibi M, Al-Msharfi M, et al. Knowledge, attitudes, and practices (KAP) toward the COVID-19 vaccine in Oman: a pre-campaign cross-sectional study. Vaccines. 2021;9(6):602. doi:10.3390/vaccines9060602.
  • Asadi Faezi N, Gholizadeh P, Sanogo M, Oumarou A, Mohamed MN, Cissoko Y, Sow MS, Keita BS, Baye YA, Pagliano P, et al. Peoples’ attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries. Health Promot Perspect. 2021;11(2):171–78. doi:10.34172/hpp.2021.21.
  • Al-Mistarehi AH, Kheirallah KA, Yassin A, Alomari S, Aledrisi MK, Bani Ata EM, Hammad NH, Khanfar AN, Ibnian AM, Khassawneh BY. Determinants of the willingness of the general population to get vaccinated against COVID-19 in a developing country. Clin Exp Vaccine Res. 2021;10(2):171–82. doi:10.7774/cevr.2021.10.2.171.
  • Hershan A. Awareness of COVID-19, protective measures and attitude towards vaccination among university of Jeddah health field community: a questionnaire-based study. J Pure Appl Microbiol 2021;15:604–612.
  • Fayed AA, Al Shahrani AS, Almanea LT, Alsweed NI, Almarzoug LM, Almuwallad RI, Almugren WF. Willingness to receive the COVID-19 and seasonal influenza vaccines among the saudi population and vaccine uptake during the initial stage of the national vaccination campaign: a cross-sectional survey. Vaccines. 2021;9(7):765. doi:10.3390/vaccines9070765.
  • Rosental H, Shmueli L. Integrating health behavior theories to predict COVID-19 vaccine acceptance: differences between medical students and nursing students in Israel. medRxiv. Vaccines. 2021;9(7):783. doi:10.3390/vaccines9070783.
  • Saied SM, Saied EM, Kabbash IA, Saef A. Vaccine hesitancy: beliefs and barriers associated with COVID‐19 vaccination among Egyptian medical students. J Med Virol. 2021;93(7):4280–91. doi:10.1002/jmv.26910.
  • Alfageeh EI, Alshareef N, Angawi K, Alhazmi F, Chirwa GC. Acceptability of a COVID-19 vaccine among the Saudi population. Vaccines. 2021;9(3):226. doi:10.3390/vaccines9030226.
  • Abu-Farha RK, Alzoubi KH, Khabour OF. Public willingness to participate in COVID-19 vaccine clinical trials: a study from Jordan. Patient Prefer Adherence. 2020;14:2451–58. doi:10.2147/PPA.S284385.
  • Mejri N, Berrazega Y, Ouertani E, Rachdi H, Bohli M, Kochbati L, Boussen H. Understanding COVID-19 vaccine hesitancy and resistance: another challenge in cancer patients. Support Care Cancer. 2021;30:289–293.
  • Al-Sanafi M, Sallam M. Psychological determinants of COVID-19 vaccine acceptance among healthcare workers in Kuwait: a cross-sectional study using the 5C and vaccine conspiracy beliefs scales. Vaccines. 2021;9(7):701. doi:10.3390/vaccines9070701.
  • AlAwadhi E, Zein D, Mallallah F, Bin Haider N, Hossain A. Monitoring COVID-19 vaccine acceptance in Kuwait during the pandemic: results from a national serial study. Risk Manag Healthc Policy. 2021;14:1413–29.
  • Al-Mohaithef M, Padhi BK. Determinants of COVID-19 vaccine acceptance in Saudi Arabia: a web-based national survey. J Multidiscip Healthc. 2020;13:1657–63. doi:10.2147/JMDH.S276771.
  • Al-Qerem WA, Jarab AS. COVID-19 vaccination acceptance and its associated factors among a Middle Eastern population. Front Public Health. 2021;9. doi:10.3389/fpubh.2021.632914.
  • Al-Mulla R, Abu-Madi M, Talafha QM, Tayyem RF, Abdallah AM. COVID-19 vaccine hesitancy in a representative education sector population in Qatar. Vaccines. 2021;9(6):665. doi:10.3390/vaccines9060665.
  • Temsah MH, Barry M, Aljamaan F, Alhuzaimi A, Al-Eyadhy A, Saddik B, Alrabiaah A, Alsohime F, Alhaboob A, Alhasan K, et al. Adenovirus and RNA-based COVID-19 vaccines’ perceptions and acceptance among healthcare workers in Saudi Arabia: a national survey. BMJ Open. 2021;11(6):e048586. doi:10.1136/bmjopen-2020-048586.
  • Fares S, Elmnyer MM, Mohamed SS, Elsayed R. COVID-19 vaccination perception and attitude among healthcare workers in Egypt. J Prim Care Community Health. 2021;12:21501327211013303. doi:10.1177/21501327211013303.
  • Aloweidi, A, et al. Hesitancy towards COVID-19 Vaccines: An Analytical Cross-Sectional Study. Int J Environ Res Public Health. 2021;18(10).
  • El-Elimat, T, et al. Acceptance and attitudes toward COVID-19 vaccines: A cross-sectional study from Jordan. PLoS One. 2021;16(4):p. e0250555.
  • Al Halabi, C.K, et al. Attitudes of Lebanese adults regarding COVID-19 vaccination. BMC Public Health:2021. 21(1)
  • Elharake, J.A, et al. COVID-19 Vaccine Acceptance among Health Care Workers in the Kingdom of Saudi Arabia. Int J Infect Dis, 2021. 109:p. 286–293.
  • Green, M.S, et al. A study of ethnic, gender and educational differences in attitudes toward COVID-19 vaccines in Israel – implications for vaccination implementation policies. Israel Journal of Health Policy Research, 2021. 10(1).
  • Hammam, N, et al. Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt. Rheumatol Int, 2021. 41(9):p. 1607–1616.
  • Maraqa, B, et al. COVID-19 vaccine hesitancy among health care workers in Palestine: A call for action. Prev Med, 2021. 149:p. 106618.
  • Omar, D.I. and B.M. Hani, Attitudes and intentions towards COVID-19 vaccines and associated factors among Egyptian adults. J Infect Public Health. 2021.
  • Palgi, Y, et al. No psychological vaccination: Vaccine hesitancy is associated with negative psychiatric outcomes among Israelis who received COVID-19 vaccination. J Affect Disord, 2021. 287:p. 352–353.
  • Qattan, A.M.N, et al. Acceptability of a COVID-19 Vaccine Among Healthcare Workers in the Kingdom of Saudi Arabia. Front Med (Lausanne), 2021. 8:p. 644300.
  • Qunaibi, E, et al. Hesitancy of arab healthcare workers towards covid-19 vaccination: A large-scale multinational study. Vaccines, 2021. 9(5).
  • Rabi, R.et al, , Factors affecting nurses' intention to accept the COVID-19 vaccine: A cross-sectional study. Public Health Nurs. 2021.